Early-stage classical Hodgkin lymphoma (stage I to II)

What changed: Early-stage classical Hodgkin lymphoma (stage I to II)

Cancer page →

Every dated change on the records linked to Early-stage classical Hodgkin lymphoma (stage I to II), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.

Milestone7This record1

FollowWatch this cancer and Saved shows what changed since you last looked.Follow by feed

September 2026 · 1

2026-09-18This recordEarly-stage classical Hodgkin lymphoma (stage I to II)
Facts on this page last checked
When this page itself was last checked or edited.

2022 · 1

2022MilestoneAHOD2131 (COG / NCTN)
AHOD2131 opens: brentuximab vedotin and nivolumab in early-stage high-risk disease from age 5
A milestone in how this cancer is treated.

2021 · 1

2021MilestonePET-adapted (response-adapted) therapy
HD17: radiotherapy omitted in PET-negative early unfavourable disease
A milestone in how this cancer is treated.

2015 · 1

2015MilestonePET-adapted (response-adapted) therapy
RAPID: PET-negative patients can omit radiotherapy at a small cost in relapse
A milestone in how this cancer is treated.

2010 · 1

2010MilestoneABVD, BEACOPP and BrECADD (Hodgkin lymphoma regimens)
GHSG HD10: two ABVD and 20 Gy suffice for early favourable disease
A milestone in how this cancer is treated.

1975 · 1

1975MilestoneABVD, BEACOPP and BrECADD (Hodgkin lymphoma regimens)
Bonadonna introduces ABVD in Milan
A milestone in how this cancer is treated.

1962 · 1

1962MilestoneIMRT / IGRT (modern external beam)
Kaplan's extended-field radiotherapy cures early-stage disease at Stanford
A milestone in how this cancer is treated.

1832 · 1

1832MilestoneReed-Sternberg cell
Thomas Hodgkin describes the disease
A milestone in how this cancer is treated.